tiprankstipranks
Genedrive PLC (GB:GDR)
LSE:GDR

Genedrive (GDR) Income Statement

11 Followers

Genedrive Income Statement

Last quarter (Q2 2023), Genedrive's total revenue was £―, a decrease of ― from the same quarter last year. In Q2, Genedrive's net income was £―. See Genedrive’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
-£ 55.00K£ 49.00K£ 687.00K£ 502.00K£ 2.36M
Cost of Revenue
------
Gross Profit
-£ 55.00K£ 49.00K---
Operating Expense
-£ 5.28M£ 5.66M£ 6.17M£ 6.14M£ 6.81M
Operating Income
-£ -5.22M£ -5.62M£ -5.48M£ -5.64M£ -4.45M
Net Non Operating Interest Income Expense
-£ -82.00K£ -16.00K£ 234.00K£ -795.00K£ -871.00K
Other Income Expense
-£ 675.00K----
Pretax Income
-£ -5.98M£ -5.63M£ -1.85M£ -20.38M£ -4.52M
Tax Provision
-£ -831.00K£ -956.00K£ -1.16M£ -965.00K£ -882.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-£ -5.15M£ -4.67M£ -691.00K£ -19.42M£ -3.64M
Basic EPS
-£ -0.06£ -0.06£ -0.01£ -0.55£ -0.14
Diluted EPS
-£ -0.06£ -0.06£ -0.01£ -0.55£ -0.14
Basic Average Shares
-£ 94.17M£ 84.86M£ 58.99M£ 35.56M£ 26.04M
Diluted Average Shares
-£ 94.17M£ 84.86M£ 58.99M£ 35.56M£ 26.04M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----£ 300.00K£ 294.00K
Total Expenses
-£ 5.28M-£ -6.17M£ 6.14M£ 6.81M
Net Income From Continuing And Discontinued Operation
-£ -5.15M£ -4.67M£ -691.00K£ -19.42M£ -3.64M
Normalized Income
-£ -6.81M£ -6.59M£ -3.01M£ -6.27M£ -4.51M
Interest Expense
----£ 808.00K£ 889.00K
EBIT
-£ -5.87M£ -5.62M£ -1.62M£ -19.58M£ -3.63M
EBITDA
-£ -5.68M£ -5.43M£ -1.62M£ -19.52M£ -3.53M
Currency in GBP

Genedrive Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis